{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:24:41Z","timestamp":1775244281759,"version":"3.50.1"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153094","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T19:39:06Z","timestamp":1459971546000},"page":"e0153094","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis"],"prefix":"10.1371","volume":"11","author":[{"given":"Susana","family":"Cubillos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Norgauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijd.12790","article-title":"The role of vitamin D in psoriasis: a review","volume":"54","author":"T Soleymani","year":"2015","journal-title":"Int J Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jaad.2015.03.017","article-title":"Phototherapy in dermatology: A call for action","volume":"72","author":"HW Lim","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/283669a0","article-title":"Osteoclasts derived from haematopoietic stem cells","volume":"283","author":"P Ash","year":"1980","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"N Takahashi","year":"1988","journal-title":"Endocrinology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","article-title":"TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts","volume":"188","author":"K Fuller","year":"1998","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors","volume":"91","author":"S Tanaka","year":"1993","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator","volume":"277","author":"N Ishida","year":"2002","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":". Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signalling in terminal differentiation of osteoclasts","volume":"3","author":"H Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"P Saftig","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1016\/S0021-9258(17)36541-9","article-title":"Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro","volume":"269","author":"B Ek-Rylander","year":"1994","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1172\/JCI112584","article-title":"Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization","volume":"78","author":"GC Nicholson","year":"1986","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S8756-3282(99)00200-8","article-title":"Effects of calcitonin on animal and in vitro models of skeletal metabolism","volume":"25","author":"S Wallach","year":"1999","journal-title":"Bone"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.96.14.8253","article-title":"Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats","volume":"96","author":"T Shinki","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","article-title":"Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1\u03b1,25-dihydroxyvitamin D(3)","volume":"40","author":"GJ Atkins","year":"2007","journal-title":"Bone"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"NJ Horwood","year":"1998","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/jbmr.5650051212","article-title":"Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro","volume":"5","author":"JS Adams","year":"1990","journal-title":"J Bone Miner Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(18)60906-8","article-title":"Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-\u03b3-stimulated normal human bone marrow and alveolar macrophages","volume":"262","author":"H Reichel","year":"1987","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2010.03.048","article-title":"The metabolism of 25-(OH)-vitamin D(3) by osteoclasts and their precursors regulates the differentiation of osteoclasts","volume":"121","author":"M Kogawa","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxy-vitamin D3. Involvement of NF-kappa B downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D D\u2019Ambrosio","year":"1998","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1704S","DOI":"10.1093\/jn\/125.suppl_6.1704S","article-title":"Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th 1 functions","volume":"125","author":"JM Lemire","year":"1995","journal-title":"J Nutr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-2478(91)90108-M","article-title":"Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3","volume":"28","author":"K Muller","year":"1991","journal-title":"Immunol Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0019-5154.127668","article-title":"Immunomodulatory mechanisms of action of calcitriol in Psoriasis","volume":"59","author":"S Raychaudhuri","year":"2014","journal-title":"Indian J Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/eji.200838216","article-title":"1,25-Dihydroxyvitamin D(3) promotes IL-10 production in human B cells","volume":"38","author":"G Heine","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI21759","article-title":"Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients","volume":"116","author":"E Xystrakis","year":"2006","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1365-2133.2012.11038.x","article-title":"A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis","volume":"167","author":"YB Choe","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00403-011-1159-3","article-title":"Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients","volume":"303","author":"H Nakajima","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3123","article-title":"Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion","volume":"12","author":"N Dalbeth","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3899\/jrheum.120397","article-title":"Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis","volume":"40","author":"A Szentpetery","year":"2013","journal-title":"J Rheumatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"CT Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"W Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02032102","article-title":"Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis","volume":"8","author":"M Magar\u00f2","year":"1989","journal-title":"Clin Rheumatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation","volume":"18","author":"P Garnero","year":"2003","journal-title":"J Bone Miner Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.45.070176.003215","article-title":"Metabolism and mechanism of action of vitamin D","volume":"45","author":"HF DeLuca","year":"1976","journal-title":"Ann Rev Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"JB Cheng","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.abb.2006.12.017","article-title":"Factors that influence the cutaneous synthesis and dietary sources of vitamin D","volume":"460","author":"TC Chen","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1080S","DOI":"10.1093\/ajcn\/87.4.1080S","article-title":"Vitamin D deficiency: a worldwide problem with health consequences","volume":"87","author":"MF Holick","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2133.2011.10699.x","article-title":"Vitamin D status in patients with chronic plaque psoriasis","volume":"166","author":"P Gisondi","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MAJ.0000000000000340","article-title":"Vitamin D serum level, disease activity and functional ability in different rheumatic patients","volume":"349","author":"S Grazio","year":"2015","journal-title":"Am J Med Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.3390\/ijerph111212108","article-title":"Vitamin D and psoriasis pathology in the Mediterranean region, Valencia (Spain)","volume":"11","author":"MM Su\u00e1rez-Varela","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/acr.20530","article-title":"Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes","volume":"63","author":"Z Touma","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2340\/00015555-0555","article-title":"Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study","volume":"89","author":"J Ga\u00e1l","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/art.1780331117","article-title":"Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study","volume":"33","author":"D Huckins","year":"1990","journal-title":"Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/derm.24808","article-title":"A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis","volume":"5","author":"DC Finamor","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF02555172","article-title":"Effect of 1 alpha-hydroxycholecalciferol on psoriasis vulgaris: a pilot study","volume":"39","author":"S Takamoto","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jdv.12176","article-title":"A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis","volume":"28","author":"TR Hata","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref46","article-title":"The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures","author":"R Scragg","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref47","unstructured":"Chulalongkorn University (Sponsor). The efficacy of vitamin D3 for the treatment of chronic plaque type psoriatic patients with vitamin D deficiency and insufficiency: a randomized controlled trial. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01339741\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01339741<\/ext-link>"},{"key":"ref48","unstructured":"Pontificia Universidad Catolica de Chile (Sponsor). Effect of vitamin D supplementation on metabolic parameters of patients with moderate to severe psoriasis. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02271971\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02271971<\/ext-link>"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone","volume":"69","author":"PV Hauschka","year":"1989","journal-title":"Physiol Rev"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.febslet.2015.04.008","article-title":"Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role","volume":"589","author":"L Hao","year":"2015","journal-title":"FEBS Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.1200901","article-title":"Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation","volume":"190","author":"T Hirai","year":"2013","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.150.3702.1465","article-title":"Thyrocalcitonin: inhibitor of bone resorption in tissue culture","volume":"150","author":"J Friedman","year":"1965","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsbmb.2015.04.003","article-title":"Effects of 1\u03b1,25-(OH)<sub>2<\/sub>D<sub>3<\/sub> on the formation and activity of osteoclasts in RAW264.7 cells","volume":"152","author":"J Gu","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1210\/endo-108-6-2293","article-title":"1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone","volume":"108","author":"ME Holtrop","year":"1981","journal-title":"Endocrinology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.175.4023.768","article-title":"1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture","volume":"175","author":"LG Raisz","year":"1972","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D<sub>3<\/sub>: A potential mechanism for optimization of bone resorption","volume":"151","author":"M Kogawa","year":"2010","journal-title":"Endocrinology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.169.5.2374","article-title":"1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts","volume":"169","author":"SK Lee","year":"2002","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00264-013-2121-0","article-title":"Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis","volume":"38","author":"M Iki\u0107","year":"2014","journal-title":"Int Orthop"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1189\/jlb.69.1.11","article-title":"Heterogeneity of human peripheral blood monocyte subsets","volume":"69","author":"E Grage-Griebenow","year":"2001","journal-title":"J Leukoc Biol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar2046","article-title":"Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts","volume":"8","author":"Y Komano","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar2616","article-title":"The proliferative human monocyte subpopulation contains osteoclast precursors","volume":"11","author":"R Lari","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0504287","article-title":"Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells","volume":"77","author":"AJ Janckila","year":"2005","journal-title":"J Leukoc Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells","volume":"116","author":"H Li","year":"2010","journal-title":"Blood"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bone.2014.10.019","article-title":"Novel immunostimulatory effects of osteoclasts and macrophages on human \u03b3\u03b4 T cells","volume":"71","author":"A Pappalardo","year":"2015","journal-title":"Bone"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcp.22411","article-title":"T cell suppression by osteoclasts in vitro","volume":"226","author":"F Grassi","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref66","first-page":"457","article-title":"Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study","volume":"76","author":"R O\u2019Keefe","year":"1997","journal-title":"Lab Invest"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1210\/endo.136.6.7750500","article-title":"Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse","volume":"136","author":"P Rahimi","year":"1995","journal-title":"Endocrinology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1210\/endo.139.10.6247","article-title":"Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8","volume":"139","author":"L Rothe","year":"1998","journal-title":"Endocrinology"},{"key":"ref69","first-page":"385","article-title":"Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis","volume":"39","author":"F Bos\u00e8","year":"2014","journal-title":"Clin Exp Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-1545","article-title":"Systemic elevated Th1-, Th2-, and Th17-associated chemokines in psoriasis vulgaris before and after ultraviolet B treatment","volume":"93","author":"AK Ekman","year":"2013","journal-title":"Acta Derm Venereol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:23:13Z","timestamp":1748845393000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153094"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Heymann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153094","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}